Investors Bag VNDA Even Lower Than Its Secondary Stock Offering
November 07, 2014 at 13:17 PM EST
Looking back to 9 days ago, Vanda Pharmaceuticals Inc (VNDA) priced a 5,000,000 share secondary stock offering at $11.60 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..